Study in mice suggests that COVID-19 increases risk of developing Parkinson’s disease
Brain fog, headaches, insomnia are some of the neurological symptoms doctors have observed in COVID-19 patients. Neurological sequelae after a…
Brain fog, headaches, insomnia are some of the neurological symptoms doctors have observed in COVID-19 patients. Neurological sequelae after a…
As explained by Francisco Camarena, researcher at the Institute of Instrumentation for Molecular Imaging, a joint center between the UPV…
Exercise increases dopamine signaling in the motor areas of mice, according to research recently published in JNeurosci. It’s no secret…
Neurodegenerative diseases damage and destroy neurons, ravaging both mental and physical health. Parkinson’s disease, which affects over 10 million people…
Although there is a growing trend to involve patients in clinical research, specific guiding principles for engaging individuals with Parkinson’s…
Parkinson’s disease is perhaps best known for its movement-related symptoms, particularly tremors and stiffness. But the disease is also known…
Accumulation of the biomarker p-syn in the skin distinguishes patients with Parkinson’s disease from patients with symptoms of parkinsonism due…
Rutgers researchers have discovered some of the first molecular insights into how toxic proteins are regulated in neurodegenerative diseases such…
Transcranial direct current stimulation (tDCS) can increase the benefits of aerobic exercise and improve the gait of patients with Parkinson’s…
Researchers from Brain Research Institute, Niigata University, Japan may have unraveled a new approach that could revolutionize the treatment, prevention,…
More than 20 years after the discovery of the parkin gene linked to young-onset Parkinson’s disease, researchers at The Ottawa…
Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated…
Neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease are in the firing line after researchers identified an attractive therapeutic drug…
Parkinson’s disease is most commonly treated with levodopa, a drug which alleviates the slowing of bodily movements, called bradykinesia, found…
Mutations in the gene LRRK2 have been linked to about three percent of Parkinson’s disease cases. Researchers have now found…